Will NVIDIA Be Knocked Off Its Perch By Quantum?
Earlier this month, NVIDIA CEO Jensen Huang seemingly dashed the hopes of speculative tech investors banking on quantum computing to become the next big thing in the ever-advancing race for faster and faster computer processing. Huang, speaking at the Consumer Electronics Show, stated his view that practical quantum computers were still about two decades away, causing a selloff among the stocks of quantum startups. » Read more about: Will NVIDIA Be Knocked Off Its Perch By Quantum? »
Read More
3 Dividend Stocks Worth Buying Now?
Thanks to surging stock prices over the past two years, dividend yields on major stock indices have fallen to fairly low levels. The S&P 500, for instance, currently carries an average yield of just 1.3%.
The mature companies in the Dow Jones Industrial Average fare a bit better, and some of them offer yields that exceed the S&P 500 several times over.
» Read more about: 3 Dividend Stocks Worth Buying Now? »
Read More
1 ETF Set To Beat The Market in 2025?
2024 was another banner year for the US stock market, with the S&P 500 notching a gain of 23%. Dwarfing even this return, though, was that of the Financial Select Sector SPDR ETF (XLF), which has delivered a 29.7% return over the last 12 months.
There is lots of speculation that the new President will be supportive of the financial sector so can XLF beat the market again in 2025,
» Read more about: 1 ETF Set To Beat The Market in 2025? »
Read More
1 Rare Stock Buffett Is Buying
Warren Buffett has spent 2024 stockpiling cash, even going so far as to sell off sizeable pieces of some of his largest investments. Recently, though, Berkshire Hathaway announced that it had made some modest acquisitions, including the addition of nearly 388,000 shares of domain name registry service Verisign (NASDAQ:VRSN).
These purchases brought Berkshire Hathaway’s holdings in Verisign to 13.2 million shares,
» Read more about: 1 Rare Stock Buffett Is Buying »
Read More
Billionaire Buys Stake In Gene Therapy Stock
Ultragenyx may not have crossed your radar but it’s already in billionaire Stan Druckenmiller’s portfolio. What has he spotted in this novel therapies for rare and ultra-rare genetic diseases firm that convinced him to take a position?
Its focus on underserved patient populations, deep pipeline of innovative products, and strong track record in obtaining regulatory approvals make it an attractive long-term investment,
» Read more about: Billionaire Buys Stake In Gene Therapy Stock »
Read MoreThe Ivy
Will New Buffett Buy 10x?
Last year, Warren Buffett surprised practically everyone when he acquired more than 30% of embattled internet radio giant Sirius XM (NASDAQ:SIRI).
At first, Buffett appeared to be taking advantage of an arbitrage opportunity, but subsequent purchases have suggested that the Oracle of Omaha is more interested in building a long-term position in Sirius XM.
» Read more about: Will New Buffett Buy 10x? »
Read MoreThe Spotlight
1 Cash Cow ETF That Beat The Market
There’s a reason even Warren Buffett advocates his heirs to buy an exchange-traded fund over Berkshire Hathaway when he passes on. They are low-cost, tax-efficient, and, for the most part, transparent.
But not all ETFs are built the same, and the Pacer US Cash Cows 100 ETF has some features that will be highly attractive to some investors.
» Read more about: 1 Cash Cow ETF That Beat The Market »
Read MoreThe Daily
Fed’s Balance-Sheet Plans Mystify Wall Street as Officials Meet
Buried in a rote US Treasury survey released on the eve of the latest holiday weekend was a question that all of Wall Street wants the answer to: What’s the Federal Reserve’s plan once it’s done drawing down its crisis-era bond holdings?
Fed officials, who are meeting this week,
» Read more about: Fed’s Balance-Sheet Plans Mystify Wall Street as Officials Meet »